|
CN104473273A
|
|
Gingko beverage and preparation method thereof
|
|
CN104434808A
|
|
Therapeutic nanoparticles and preparation method thereof
|
|
US2015030672A1
|
|
Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt
|
|
CN105330653A
|
|
Quinazoline derivatives
|
|
CN104758937A
|
|
Metoprolol sustained-release pellet preparation
|
|
CN104739828A
|
|
Ertapenem disodium pharmaceutical composition and preparation method thereof
|
|
CN104739780A
|
|
Ertapenem disodium pharmaceutical composition and preparation method thereof
|
|
CN104710425A
|
|
Ticagrelor new crystal and preparation method thereof
|
|
CN104415053A
|
|
Anti-oxidation and anti-aging composition
|
|
CN104342416A
|
|
Lovastatin acyltransferase containing one or more point mutations
|
|
CN104274420A
|
|
Dasatinib composition and preparation method thereof
|
|
CN104248769A
|
|
Lurasidone pharmaceutical composition and preparation method thereof
|
|
CN104224772A
|
|
A pharmaceutical composition comprising butylphthalide and borneol and applications thereof
|
|
CN104107422A
|
|
Pharmaceutical composition of recombinant glucagon-like peptide-1 receptor stimulant for injection
|
|
CN104072497A
|
|
Doripenem novel crystal and preparation method thereof
|
|
CN104031917A
|
|
SiRNA directed at HBx and liposome preparation thereof
|
|
CN103058967A
|
|
Method for producing dronedarone hydrochloride
|
|
CN102924439A
|
|
Preparation method of iloperidone
|
|
CN102920666A
|
|
Cefozopran hydrochloride freeze-dried powder
|
|
CN102860985A
|
|
Tebipenem pivoxil oral preparation and preparation method thereof
|
